The European Science Foundation recently concluded a foresight study on the topic of nanotechnology applied to medicine (Scientific Forward Look on Nanomedicine). The goal of this Forward Look was to exchange views on the current status of Nanomedicine between scientific experts and policy makers, and to reflect upon future developments, opportunities and challenges facing this important field in Europe and world wide. Over 100 international experts from academia, industry, private foundations and governmental agencies supporting scientific research have contributed to this activity.
The ESF Forward Look on Nanomedicine has led to a definition of the current status of the field and debates on strategic policy issues. An ESF Policy Briefing, which summarises recommendations from this Forward Look activity, is going to be published on 1 March 2005 (see this document). This policy paper provides only a brief summary of in-depth discussions throughout the foresight study. A full report documenting the detailed debate and analysis will be published separately.
Implementation of recommendations from the ESF Scientific Forward Look on Nanomedicine would strengthen Europe’s leading-edge research and ensure further development in Nanomedicine, resulting in reduced healthcare costs and the rapid realisation of medical benefits for all European citizens.
Source: European Science Foundation (ESF)
Explore further: Nanobiotix looks to bring cancer treatment to market